Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A malignant germ cell tumor arising from the ovary. Morphologically, it is identical to seminoma and consists of a monotonous population of germ cells with abundant pale cytoplasm and uniform nuclei. The stroma invariably contains chronic inflammatory cells, mostly T-lymphocytes. It responds to chemotherapy or radiotherapy and the prognosis relates to the tumor stage.
1 clinical trial registered. Interventions under study include drug therapy. Pipeline includes 1 PHASE2. Research is primarily sponsored by academic and government institutions.
17 publications have been identified in PubMed for dysgerminoma of ovary. Research spans Case Report / Case Series (71%), Epidemiology / Natural History (18%), and Review / Meta-Analysis (6%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 12 | 71% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 5:34 PM UTC
Disease patterns and progression |
3 |
18% |
Research summaries | 1 | 6% |
Laboratory research | 1 | 6% |
Yoshida S (2026). [PMID: 41806988](https://pubmed.ncbi.nlm.nih.gov/41806988/). *BMJ case reports*. [Case Report / Case Series]
Zanfagnin V (2026). [PMID: 41887253](https://pubmed.ncbi.nlm.nih.gov/41887253/). *Arch Pathol Lab Med*. [Basic Science / Preclinical]
Abdelli FZ (2025). [PMID: 40556791](https://pubmed.ncbi.nlm.nih.gov/40556791/). *Ecancermedicalscience*. [Case Report / Case Series]
Xue Y (2025). [PMID: 40248274](https://pubmed.ncbi.nlm.nih.gov/40248274/). *Gynecol Oncol Rep*. [Case Report / Case Series]
De Maria F (2025). [PMID: 40275685](https://pubmed.ncbi.nlm.nih.gov/40275685/). *Journal of gynecologic oncology*. [Epidemiology / Natural History]
Friedrich L (2025). [PMID: 38953909](https://pubmed.ncbi.nlm.nih.gov/38953909/). *Minerva obstetrics and gynecology*. [Review / Meta-Analysis]
Bayramoglu Z (2025). [PMID: 41000187](https://pubmed.ncbi.nlm.nih.gov/41000187/). *Frontiers in pediatrics*. [Case Report / Case Series]
Li X (2025). [PMID: 41018086](https://pubmed.ncbi.nlm.nih.gov/41018086/). *Frontiers in oncology*. [Case Report / Case Series]
Graham KS (2025). [PMID: 39168413](https://pubmed.ncbi.nlm.nih.gov/39168413/). *Urology*. [Case Report / Case Series]
Park HK (2025). [PMID: 41303827](https://pubmed.ncbi.nlm.nih.gov/41303827/). *Medicina (Kaunas, Lithuania)*. [Epidemiology / Natural History]